• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对在英国向黄卡计划报告药物不良反应的看法和体验。

Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.

机构信息

Medical Statistics Team, Section of Population Health, University of Aberdeen, Aberdeen, UK.

出版信息

Pharmacoepidemiol Drug Saf. 2011 May;20(5):523-31. doi: 10.1002/pds.2117. Epub 2011 Feb 17.

DOI:10.1002/pds.2117
PMID:21328634
Abstract

PURPOSE

To describe the characteristics of patient reporters to the UK's Yellow Card Scheme (YCS) and the suspect drugs reported, and to determine patient views and experiences of making a Yellow Card report.

METHODS

A questionnaire was developed for distribution by the Medicines and Healthcare products Regulatory Agency (MHRA) to all patients reporting through the YCS between March 2008 and January 2009. Associations between reporting method (online, postal and telephone) and questionnaire responses were examined using Pearson's Chi-squared test.

RESULTS

Evaluable questionnaires were returned by 1362 out of 2008 reporters (68%). Respondents' median (IQR) age was 56.5 (43.0, 67.0) years, 910 (66.8%) were female, 1274 (93.5%) were white and 923 (67.8%) had at least a further education qualification. The most frequent reporting method was postal (59.8%), followed by online (32.8%) and telephone (6.3%). Online reporters were younger with a higher education level than those using other reporting methods. Most respondents, 1274 (93.6%), thought that the report was fairly or very easy to complete, although many identified the need for improvements to the system. One third (n = 448; 32.9%) expected feedback from the MHRA and 828 (60.8%) would have liked feedback. Almost all respondents (n = 1302; 95.6%) would report again.

CONCLUSIONS

The majority of patients found the current methods of reporting suspected ADRs easy to use and would recommend them to others. Different methods of reporting were used by different demographic subgroups of reporters. Improvements to the system, including the provision of feedback to reporters, could be made.

摘要

目的

描述向英国黄卡计划(YCS)报告的患者报告者的特征和报告的可疑药物,并确定患者对提出黄卡报告的看法和体验。

方法

为了向在 2008 年 3 月至 2009 年 1 月期间通过 YCS 报告的所有患者分发调查问卷,由药品和保健产品监管局(MHRA)开发。使用 Pearson 卡方检验检查报告方法(在线,邮寄和电话)与问卷答复之间的关联。

结果

在 2008 名报告者中有 1362 名(68%)报告了可评估的问卷。应答者的中位数(IQR)年龄为 56.5(43.0,67.0)岁,910 名(66.8%)为女性,1274 名(93.5%)为白人,923 名(67.8%)具有至少进一步的教育资格。最常见的报告方法是邮寄(59.8%),其次是在线(32.8%)和电话(6.3%)。在线报告者比其他报告者年龄更小,教育程度更高。大多数受访者(n = 1274;93.6%)认为报告非常容易或容易完成,尽管许多人认为系统需要改进。三分之一(n = 448;32.9%)期望从 MHRA 获得反馈,而 828(60.8%)希望获得反馈。几乎所有受访者(n = 1302;95.6%)将再次报告。

结论

大多数患者认为当前报告可疑 ADR 的方法易于使用,并会向他人推荐。不同的报告方法被不同的报告者人口统计学亚组使用。可以对系统进行改进,包括向报告者提供反馈。

相似文献

1
Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.患者对在英国向黄卡计划报告药物不良反应的看法和体验。
Pharmacoepidemiol Drug Saf. 2011 May;20(5):523-31. doi: 10.1002/pds.2117. Epub 2011 Feb 17.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.直接由患者报告疑似药物不良反应的重要性:患者视角。
Br J Clin Pharmacol. 2011 Nov;72(5):806-22. doi: 10.1111/j.1365-2125.2011.03990.x.
4
How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.患者记者如何识别药物不良反应:通过英国黄卡计划报告的定性研究。
Drug Saf. 2011 May 1;34(5):429-36. doi: 10.2165/11589320-000000000-00000.
5
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.英国的药物不良反应报告:患者和医疗保健专业人员提交的黄卡报告的回顾性观察比较。
Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000.
6
How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.患者如何有助于信号检测?:英国黄卡计划中自发报告药物不良反应的回顾性分析。
Drug Saf. 2013 Mar;36(3):199-206. doi: 10.1007/s40264-013-0021-2.
7
Views of British community pharmacists on direct patient reporting of adverse drug reactions (ADRs).英国社区药剂师对直接向患者报告药物不良反应(ADR)的看法。
Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1130-3. doi: 10.1002/pds.3306. Epub 2012 Jun 22.
8
Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.英国公众对药物不良反应患者报告认知情况的调查评估。
J Clin Pharm Ther. 2012 Apr;37(2):161-5. doi: 10.1111/j.1365-2710.2011.01273.x. Epub 2011 May 18.
9
Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.英国非医学开处方者报告药品不良反应的培训及能力经验
J Clin Pharm Ther. 2019 Feb;44(1):78-83. doi: 10.1111/jcpt.12756. Epub 2018 Sep 11.
10
The use of electronic reporting to aid surveillance of ADRs in children: a proof of concept study.利用电子报告辅助儿童不良反应监测:概念验证研究。
Arch Dis Child. 2010 Apr;95(4):262-5. doi: 10.1136/adc.2009.158766.

引用本文的文献

1
Pharmacovigilance and Adverse Drug Reaction Reporting among the General Public in Lithuania: A Cross-Sectional Study.立陶宛公众中的药物警戒与药品不良反应报告:一项横断面研究
Healthcare (Basel). 2023 Apr 14;11(8):1133. doi: 10.3390/healthcare11081133.
2
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries.九个选定国家的患者药物不良反应报告系统比较。
Int J Environ Res Public Health. 2022 Apr 7;19(8):4447. doi: 10.3390/ijerph19084447.
3
Distributed Ledger Infrastructure to Verify Adverse Event Reporting (DeLIVER): Proposal for a Proof-of-Concept Study.
用于验证不良事件报告的分布式账本基础设施(DeLIVER):概念验证研究提案
JMIR Res Protoc. 2021 Jun 10;10(6):e28616. doi: 10.2196/28616.
4
Public Perspectives of Using Social Media Data to Improve Adverse Drug Reaction Reporting: A Mixed-Methods Study.公众对利用社交媒体数据改善药物不良反应报告的看法:一项混合方法研究。
Drug Saf. 2021 May;44(5):553-564. doi: 10.1007/s40264-021-01042-6. Epub 2021 Feb 13.
5
A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers.一项横断面调查研究,旨在了解韩国消费者对药物不良反应自发报告的知识、态度和意愿。
BMC Public Health. 2020 Oct 8;20(1):1527. doi: 10.1186/s12889-020-09635-z.
6
Use of information sources regarding medicine side effects among the general population: a cross-sectional survey.普通人群中药物副作用信息来源的使用情况:一项横断面调查。
Prim Health Care Res Dev. 2019 Dec 10;20:e153. doi: 10.1017/S1463423619000574.
7
The Role of European Patient Organizations in Pharmacovigilance.欧洲患者组织在药物警戒中的作用。
Drug Saf. 2019 Apr;42(4):547-557. doi: 10.1007/s40264-018-0748-x.
8
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers.阿拉伯联合酋长国药剂师和开处方者的药品不良反应报告行为
Hosp Pharm. 2017 May;52(5):361-366. doi: 10.1177/0018578717715364. Epub 2017 May 1.
9
Public confidence in ADR identification and their views on ADRreporting: mixed methods study.公众对药品不良反应识别的信心及其对药品不良反应报告的看法:混合方法研究
Eur J Clin Pharmacol. 2017 Feb;73(2):223-231. doi: 10.1007/s00228-016-2155-5. Epub 2016 Nov 11.
10
Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.患者对药物不良反应的报告:各国主管当局观点与需求的国际调查
Drug Saf. 2016 Nov;39(11):1105-1116. doi: 10.1007/s40264-016-0453-6.